iSpecimen
ISPC
10 hedge funds and large institutions have $69.1K invested in iSpecimen in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
65% less capital invested
Capital invested by funds: $196K → $69.1K (-$127K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$9.87K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$7.77K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.06K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $17.8K | -$25.4K | -72 | -43% |
|
2
BlackRock
New York
| $13.1K | – | – | – |
|
|
3
Millennium Management
New York
| $10.2K | +$9.87K | +28 | +104% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $8.93K | – | – | – |
|
|
GC
5
Grimes & Company
Westborough,
Massachusetts
| $7.15K | – | – | – |
|
|
SSA
6
Schonfeld Strategic Advisors
New York
| $3.53K | -$1.06K | -3 | -14% |
|
7
Northern Trust
Chicago,
Illinois
| $3.2K | – | – | – |
|
|
MSFS
8
Main Street Financial Solutions
Newtown,
Pennsylvania
| $2.44K | – | – | – |
|
9
Renaissance Technologies
New York
| $2K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $739 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $10 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$19.4K | -49 | Closed |
|
|
13
Osaic Holdings
Scottsdale,
Arizona
| – | -$7.77K | -19 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$7 | – | – |
|
ISPC Hedge Fund Activity: Q1 2024 in Review
10 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q1 2024, worth a combined $69.1K — down 65% from $196K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ISPC and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, adding an estimated $9.87K. The largest seller was Vanguard Group, cutting an estimated $25.4K.
- 10 institutional investors held iSpecimen (ISPC) as of Q1 2024, down from 12 in Q4 2023.
- Funds reported $69.1K of iSpecimen stock for Q1 2024, down 65% quarter-over-quarter.
- 0 funds opened new iSpecimen positions in Q1 2024 and 2 closed out, a net change of -2 holders.
- The largest iSpecimen buyer in Q1 2024 was Millennium Management, an estimated $9.87K added.
- The largest iSpecimen seller in Q1 2024 was Vanguard Group, an estimated $25.4K sold.
Based on aggregated 13F filings for Q1 2024.